912 results on '"Vogelmeier,Claus F"'
Search Results
2. Hausärztliches Telemonitoring bei akuten Erkrankungen am Beispiel von COVID-19 – qualitative Interviewstudie
3. Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians
4. Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
5. Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET
6. Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
7. GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
8. Genetisch bedingte Lungenerkrankungen
9. Gold 2023: Highlights for primary care
10. In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
11. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
12. Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
13. Effectiveness of Single Versus Multiple Inhaler Triple Therapy on Mortality and Cardiopulmonary Risk Reduction in COPD: The SKOPOS-MAZI Study
14. Potential systemic effects of acquired CFTR dysfunction in COPD
15. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
16. A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”
17. COPD and multimorbidity: recognising and addressing a syndemic occurrence
18. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
19. Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap
20. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network
21. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
22. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis
23. Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis
24. Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET
25. A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic
26. Lungenerkrankung nach Senfgasexposition
27. Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
28. Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET.
29. Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function
30. Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
31. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
32. IgE is associated with exacerbations and lung function decline in COPD
33. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
34. Cardiovascular predictors of mortality and exacerbations in patients with COPD
35. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease
36. COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort
37. Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis
38. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
39. Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial
40. Constitutive immune activity promotes JNK- and FoxO-dependent remodeling of Drosophila airways
41. Transcriptional analysis identifies potential biomarkers and molecular regulators in acute malaria infection
42. Improving lung health in low-income and middle-income countries: from challenges to solutions
43. Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten
44. Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET.
45. Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany.
46. COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development
47. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
48. Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort
49. Assessing Symptom Burden
50. Goals of COPD treatment: Focus on symptoms and exacerbations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.